As ppar modulators for the treatment of type 2 diabetes and atherosclerosis 4- (3- (2-phenyl - oxazol-4-ylmethoxy) - cyclohexyloxy) - butanoic acid derivatives and related compounds

The present invention is aryl - relates cycloalkyl-substituted alkanoic acid derivatives and salts and physiologically functional derivatives may fit on the physiology. The present invention (wherein the groups have the meanings attachments) a compound of formula (I) relates to a salt and a manufacturing method thereof can be adapted on its physiology. The compounds can be used, for example, disorders of fatty acid metabolism, disorders related glucose utilization, in addition the treatment and / or prevention of insulin-related disorders.